DEVELOPMENTAL NEUROSCIENCE, published by KARGER, is a vital academic journal dedicated to advancing the field of neurodevelopmental research. Since its inception in 1978, this journal has been instrumental in disseminating high-quality studies that explore the complexities of brain development and function throughout the lifespan. With an impact factor that places it in the second quartile (Q2) of Developmental Neuroscience and Neurology categories, it ranks among the top publications in its field, offering valuable insights for researchers, clinicians, and students alike. Though primarily subscription-based, the journal remains committed to fostering academic discourse and collaboration through its extensive repository of original research articles, reviews, and case studies. The journal is located at ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, and its scope spans critical areas of inquiry within developmental neurology, providing a platform for emerging ideas and methodologies. As such, DEVELOPMENTAL NEUROSCIENCE serves not only as a critical resource for seasoned professionals but also as an enriching educational tool for the next generation of neuroscientists.

Birth Defects Research is a premier open-access academic journal published by WILEY, dedicated to advancing the field of developmental biology and embryology, with an emphasis on understanding the mechanisms and factors influencing congenital anomalies. Since its establishment, the journal serves as a vital resource for researchers, professionals, and students alike, providing a platform for innovative research and insights in areas including pediatrics, toxicology, and health science. With an impact factor reflecting its commitment to quality, it is positioned in the Q2 and Q3 quartiles across several categories for 2023, demonstrating its relevance and influence within the scientific community. Researchers will find it particularly valuable for disseminating findings and encouraging interdisciplinary collaboration in combatting birth defects and improving child health outcomes. Accessible from the United Kingdom, the journal fosters the free exchange of information, reinforcing its goal to support the global health landscape through knowledge and innovation.

DEVELOPMENTAL NEUROPSYCHOLOGY (ISSN: 8756-5641; E-ISSN: 1532-6942) is a pivotal peer-reviewed journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD in the United Kingdom. Since its inception in 1985, this esteemed journal has been dedicated to advancing the understanding of developmental processes that influence neuropsychological outcomes in children and adolescents. With a focus on the integration of psychological and neuropsychological perspectives, it serves as a vital resource for researchers, clinicians, and educators alike. The journal's current impact factor and its placement in the third quartile for both Developmental and Educational Psychology and Neuropsychology categories underscore its significance in the field, as it ranks in the 45th percentile in both Scopus ranks. While DEVELOPMENTAL NEUROPSYCHOLOGY does not offer open access, it presents crucial research findings and theoretical advancements that cater to professionals seeking to deepen their knowledge and application of developmental neuropsychology until 2024. By fostering dialogue among scholars and practitioners, this journal contributes meaningfully to the ongoing evolution of clinical practices and educational strategies targeting neurodevelopmental trajectories.

GENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.

Frontiers in Toxicology, published by Frontiers Media SA, is a prominent open-access journal dedicated to advancing the understanding of toxicological science. Established in 2019, it serves as a vital forum for innovative research, offering insights into the pharmacological impacts and toxicological profiles of various substances. With its international reach based in Switzerland, this journal has quickly ascended in the academic community, achieving a notable Q1 ranking in Pharmacology, Toxicology and Pharmaceutics (Miscellaneous) and a Q2 ranking in Toxicology as of 2023. The journal is indexed in Scopus, where it ranks #8 out of 43 in its primary category, underscoring its influence and relevance in the field. The scope encompasses cutting-edge studies on the mechanisms of toxicity, including both human and environmental impacts, making it an essential resource for researchers, professionals, and students alike. By promoting open access to high-quality research, Frontiers in Toxicology plays a crucial role in enhancing knowledge sharing and fostering collaboration across disciplines.

Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

The INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE is a critical platform for disseminating cutting-edge research in the field of developmental biology and neuroscience. Published by WILEY, this esteemed journal has been contributing to the academic community since its inception in 1983, and continues to serve as a vital resource through to 2024. With an impact factor that reflects its influence in the field—ranking in Q3 for both Developmental Biology and Developmental Neuroscience—this journal presents an opportunity for researchers, professionals, and students alike to engage with pioneering studies and extend their understanding of complex developmental processes. Although not open access, the journal provides an essential repository of knowledge for those seeking to explore the nuances of neurological development and related disciplines. It actively supports academic discourse and research dissemination, thereby playing a significant role in advancing our collective understanding of developmental neuroscience.

NEUROTOXICITY RESEARCH is a premier journal published by SPRINGER, focusing on the critical and evolving field of neurotoxicology. With an ISSN of 1029-8428 and an E-ISSN of 1476-3524, this journal serves as a vital platform for researchers, professionals, and students dedicated to understanding the impact of toxic substances on nervous system health. Established in 1999, NEUROTOXICITY RESEARCH has consistently contributed significant findings and discussions that influence both theoretical and applied neuroscience. The journal's impressive Q2 ranking in both Neuroscience (miscellaneous) and Toxicology categories, alongside its strong percentile rankings in Scopus, underscores its relevance and quality in the academic community. While this journal is not open access, it remains a critical resource for those seeking interdisciplinary insights into the mechanisms of neurotoxicity. The objective of NEUROTOXICITY RESEARCH is to elucidate the intricate interactions between environmental and chemical agents and their neurotoxic effects, guiding future research and policies aimed at safeguarding neurological health. Based in the United States at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, this journal is committed to advancing the understanding of neurotoxic mechanisms and fostering collaborative efforts within the scientific community.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

Frontiers in Integrative Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the intricate workings of the nervous system. Since its inception in 2007, this journal has become a key resource for researchers and professionals in the field, covering a wide range of topics including cellular and molecular neuroscience, cognitive neuroscience, and sensory systems. With a reputation bolstered by its open-access model, Frontiers in Integrative Neuroscience aims to promote expedient dissemination of high-quality research, ensuring that all findings are readily accessible to the scientific community and beyond. The journal has achieved a commendable recognition, ranking in the upper tiers of its respective categories according to Scopus, with a Q2 ranking in both cognitive neuroscience and sensory systems, and a Q3 ranking in cellular and molecular neuroscience. Based in Switzerland, it continues to be a pivotal platform for innovative research that shapes our understanding of neural dynamics, encouraging collaboration and knowledge exchange among scholars worldwide.